News | News By Subject | News by Disease News By Date | Search News

Ulcerative colitis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Gilead (GILD) Looking Even Weaker on the R&D Front as It Racks Up Some More Clinical Failures in Q3 Report     11/2/2016
Gilead (GILD) Terminates Phase II/III Study of Ulcerative Colitis Drug     9/23/2016
More Positive Phase III Data for Pfizer (PFE)'s Xeljanz in Ulcerative Colitis     7/29/2016
Booming Seres Therapeutics Looks to Move Lead Product into Phase III, Expand in Cambridge     4/14/2016
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015     3/24/2016
Pfizer (PFE)'s Oral Tofacitinib Meets Primary and Key Secondary Endpoints in Two Late-Stage Trials     3/18/2016
Galapagos (GLPG.BR) Shuts Down Ulcerative Colitis Program After Drug Failed to Prove Efficacy in Trial     1/26/2016
Arena (ARNA) to Chop 35% of U.S. Workforce and Push Clinical Programs Forward     10/29/2015
Top 10 Best-Selling Biotech Drugs     10/2/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Receptos (RCPT) Soars As Bowel Disorder Drug Meets Phase 2 Goals     10/28/2014
Cannabis Biopharma GW Pharmaceuticals Sees Disappointing Data For Colitis Drug     10/15/2014
Galapagos NV (GLPG.BR), GlaxoSmithKline (GSK) Abandon Joint Drug Project Due To Adverse Effects     8/11/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Entyvio Wins FDA Approval For Severe Colitis     5/22/2014

News from Around the Web
Vinegar Could Potentially Help Treat Ulcerative Colitis, Published In Journal Of Agricultural And Food Chemistry     2/11/2016
Mothers Can Pass Traits To Offspring Through Bacteria's DNA, Washington University in St. Louis Study     2/23/2015
Laughing Quiets Leg Ulcer's Misery, University of Leeds Study     3/10/2011
Worm Therapy Shows Promise for Ulcerative Colitis, New York University Study     12/2/2010
Discovery May Aid Remission Of Ulcerative Colitis, McMaster University Study     6/15/2010
Genes Linked to Ulcerative Colitis Identified At Cedars-Sinai Medical Center     3/18/2010
Gene Discovery Gives Clues to Crohn's Disease, Colitis, University College London Study     11/5/2009
Mayo Clinic Study Reveals Infliximab Reduces The Need For Colectomy     10/2/2009
Ulcerative Colitis Treatment Reduces Need for Surgery by Almost Half, Mayo Clinic Study     10/1/2009
Intestinal Bacteria Promote and Prevent Inflammatory Bowel Disease, Harvard Medical School, Brigham and Women's Hospital, and California Institute of Technology Study Finds     5/29/2008
Discontinued Drug Helps Ulcerative Colitis     12/20/2007
New Therapeutic Targets in the Treatment of Ulcerative Colitis     11/14/2007
Scientists Find Gene Target That May Protect Against Crohn's Disease And Ulcerative Colitis     10/27/2006
Colitis Patients Need Better Immunization: Report     8/31/2006
Data In New England Journal of Medicine Show Benefits Of REMICADE In Ulcerative Colitis Patients     12/8/2005

Press Releases
Protagonist (PTGX) Release: Pharma Initiates Phase 2b Study Of Oral Drug Candidate PTG-100 In Ulcerative Colitis     1/17/2017
Galapagos (GLPG.BR) Release: Start Phase 2b/3 Study With Filgotinib In Ulcerative Colitis     12/9/2016
Takeda (TKPYY) Release: New Treatment For Ulcerative Colitis And Crohn’s Disease Launched In UAE     11/29/2016
Pfizer (PFE) to Launch Cheaper Version of Johnson & Johnson (JNJ)'s Remicade in November     10/18/2016
Celgene (CELG) Release: Oral Ozanimod Efficacy And Safety Results From Phase II TOUCHSTONE Extension Trial In Patients With Ulcerative Colitis To Be Presented At UEGW And American College of Gastroenterology     10/17/2016
First Patients Dosed In TopiVert’s Phase IIa Proof-Of-Concept Study In Moderate To Severe Ulcerative Colitis     10/6/2016
Theravance Biopharma (TBPH) Announces First Subject Dosed In Phase 1b Clinical Trial Of TD-1473 In Patients With Moderate To Severe Ulcerative Colitis     10/5/2016
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: Favorable Benefit: Risk Profile For Vedolizumab As Induction And Maintenance Therapy In TNF-Naïve Or TNF-Failure Patients With Moderately To Severely Active Ulcerative Colitis Published In Clinical Gastroenterology And Hepatology     9/16/2016
Lycera Announces Initiation Of Phase 2 Clinical Trial Of LYC-30937-EC In Patients With Ulcerative Colitis     8/22/2016
Immune Pharma Release: New Data Suggests Improved Tumor Response For The Combination of AZIXA and Immune Checkpoint Inhibitors in The Treatment of Cancer     6/28/2016
Pfizer Canada Release: Health Canada Approves INFLECTRA (Biosimilar Infliximab) For Three Additional Indications: Crohn's Disease, Fistulising Crohn's Disease And Ulcerative Colitis     6/15/2016
Digestive Disease Week Release: Transplanting Healthy Stool Might Be An Answer To Ulcerative Colitis     5/25/2016
Otsuka Pharma Release: 48-Week Data, Presented At The Digestive Disease Week (DDW) Meeting Today, Showed Clinical Benefit With Adacolumn In A Sub-Group Of Refractory Patients With Ulcerative Colitis     5/23/2016
Takeda (TKPYY) Presents Analyses From Vedolizumab Data In Ulcerative Colitis At 2016 Digestive Disease Week (DDW) Annual Meeting     5/23/2016
Protagonist Therapeutics To Present New Data For PTG-100 And PTG-200 At Digestive Disease Week 2016     5/17/2016